Rate My Professor Andre Mu

As a microbial ecologist and bioinformatician, Andre Mu investigates the mechanisms by which commensal microorganisms influence host health and disease, focusing on the human gut microbiome and infectious diseases. His research employs culture-dependent and independent techniques, including multi-omics (metagenomics, transcriptomics, metabolomics), computational biology, and bacterial physiology assays to develop gut microbiome engineering strategies for therapeutic applications. Notable contributions include leading experimental phases of Bioplatforms Australia's Antibiotic Resistant Pathogens Initiative, identifying core targets in sepsis-causing bacteria, and characterizing microbiome responses to bacteriophage therapy in clinical infections. Key publications feature 'A gut microbial signature for combination immune checkpoint blockade across cancer types' in Nature Medicine (2024), 'Primary succession of Bifidobacteria drives pathogen resistance in neonatal microbiota assembly' in Nature Microbiology (2024), 'The growing repertoire of phage anti-defence systems' in Trends in Microbiology (2024), and 'Highly stable bacteriophages PIN1 and PIN2 have hallmarks of flagellotropic phages but infect immotile bacteria' in npj Viruses (2025). His work, cited over 1,457 times on Google Scholar, advances understanding of antibiotic resistance, phage therapy, and microbial succession.